Why Is Diversity Important? FDA Action Plan In 2012 the Food and Drug Administration Safety and Innovation Act was published. Most of this FDA Action plan is based to encourage researchers to include safety and effectiveness data by demographic subgroups, including…
Landmark Clinical Trial to Help Juvenile Idiopathic Arthritis Sufferers
A clinical trial funded by Arthritis Research UK and the National Institute for Health Research (NIHR), led by professors from the Universities of Liverpool and Bristol, has discovered a drug combination that could help thousands of children with Juvenile Idiopathic Arthritis….
Inside FOMAT: Clinical Research Coordinator at FOMAT Involved in Important Research
Carla Geovanna Rodríguez Proaño is an Ecuadorian Biotechnology Engineer, who also obtained a master’s degree in Forensic Science, from King’s College in London. She has been conducting clinical research with FOMAT Medical Research since last year and was recently involved in…
How to boost Hispanics’ participation in clinical trials? Relate to them, study shows
Hispanic cancer patients rarely participate in clinical trials, but researchers want to tailor a Spanish DVD to help change this. To create a relevant educational tool, Moffitt Cancer Center researchers investigated why awareness of and participation in trials are so low…
Faster Drug & Medical Device Approvals Under 21st Century Cures Act Raises Patient Safety Concerns
President Obama signed a bill that will provide US$6 billion in federal funding for basic medical research on Dec. 13. Called the 21st Century Cures Act, it also introduces changes to how the Food and Drug Administration approves drugs and medical devices, creating…
Wearable Device Developed for Type 2 Diabetes
Although effective for the treatment of diabetes, exercise is sometimes difficult for overweight or elderly people. A new wearable medical device developed by Kumamoto University has been found to effect visceral fat loss and improve blood glucose (sugar). The current study…
Innovative Approaches in Ocular Drug Delivery
The estimated number of visually impaired people in the world is 285 million, with 39 million blind people. About 65 percent of visually impaired people and 82 percent of all blind people are 50 years or older. Four major blinding diseases…
Scientists Begin Testing Zika Vaccine in Humans
On Monday scientists began a Phase 1 human clinical trial to test safety and immunogenicity, or the ability to provoke an immune response, of the Zika purified inactivated virus (ZPIV) vaccine. The study, supported by the National Institutes of Health’s National…
Minority Inclusion in Clinical Trials: When Diversity Priorities Show
Beyond the critical need for securing more study volunteers across the board in clinical trials, a popular concern in all areas of clinical research is achieving inclusion in clinical trials and promoting diversity. Whether in medical journals, popular press, social media,…
Colombian Pharmaceutical Market to See Strong Four Year Growth
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.1 billion by 2020, registering a compound annual growth rate (CAGR) of 7.3%, according to research and consulting firm GlobalData. The company’s latest report states that this substantial…